Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report

M. Hudec, O. Jiravsky, R. Spacek, R. Neuwirth, L. Knybel, L. Sknouril, J. Cvek, R. Miklik

. 2021 ; 5 (8) : ytab184. [pub] 20210831

Jazyk angličtina Země Velká Británie

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024040

Background: Refractory angina pectoris (AP) significantly impairs quality of life in patients with chronic coronary syndrome. Several minimally invasive methods (coronary sinus reducer, cell therapy, laser or shockwave revascularization, and spinal cord stimulation) or non-invasive methods (external counterpulzation) have been studied. However, their routine clinical use has not been widely implemented. Surgical or endoscopic sympathectomy is feasible for permanently relieving angina, but is often contraindicated due to the extent of complications associated with it. Neuromodulation by anaesthetic blockade of the left-sided stellate ganglion (SG) has been shown to relieve angina for days or weeks. To provide a long-term anti-anginal effect, novel pharmacological (phenol-based) or radiofrequency ablation techniques have been individually used to permanently destroy sympathetic pathways. Case summary: We describe a first-in-man use of stereotactic radiosurgical SG ablation using a linear accelerator (CyberKnife) in a heart failure patient after myocardial infarction with chronic refractory AP. Repeated anaesthetic SG blockade in this patient resulted in a significant, but only short-term, clinical improvement. The left, and subsequently the right, SG was ablated by targeted irradiation. During the 1-year follow-up, the patient remained without angina. We did not observe any clinically relevant early or late complications. Atrial fibrillation that developed 2 months after the second procedure was deemed to be associated with a natural progression of co-existing heart failure. Discussion: We conclude that stereotactic radiosurgical SG ablation has the potential to become a minimally invasive and low-risk procedure to treat refractory angina patients. However, this procedure needs to be evaluated in larger patient populations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024040
003      
CZ-PrNML
005      
20211013134054.0
007      
ta
008      
211006s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ehjcr/ytab184 $2 doi
035    __
$a (PubMed)34514297
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Hudec, Miroslav $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia $u Faculty of Medicine, Masaryk University, Kamenice 735/5, Brno 625 00, Czechia
245    10
$a Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report / $c M. Hudec, O. Jiravsky, R. Spacek, R. Neuwirth, L. Knybel, L. Sknouril, J. Cvek, R. Miklik
520    9_
$a Background: Refractory angina pectoris (AP) significantly impairs quality of life in patients with chronic coronary syndrome. Several minimally invasive methods (coronary sinus reducer, cell therapy, laser or shockwave revascularization, and spinal cord stimulation) or non-invasive methods (external counterpulzation) have been studied. However, their routine clinical use has not been widely implemented. Surgical or endoscopic sympathectomy is feasible for permanently relieving angina, but is often contraindicated due to the extent of complications associated with it. Neuromodulation by anaesthetic blockade of the left-sided stellate ganglion (SG) has been shown to relieve angina for days or weeks. To provide a long-term anti-anginal effect, novel pharmacological (phenol-based) or radiofrequency ablation techniques have been individually used to permanently destroy sympathetic pathways. Case summary: We describe a first-in-man use of stereotactic radiosurgical SG ablation using a linear accelerator (CyberKnife) in a heart failure patient after myocardial infarction with chronic refractory AP. Repeated anaesthetic SG blockade in this patient resulted in a significant, but only short-term, clinical improvement. The left, and subsequently the right, SG was ablated by targeted irradiation. During the 1-year follow-up, the patient remained without angina. We did not observe any clinically relevant early or late complications. Atrial fibrillation that developed 2 months after the second procedure was deemed to be associated with a natural progression of co-existing heart failure. Discussion: We conclude that stereotactic radiosurgical SG ablation has the potential to become a minimally invasive and low-risk procedure to treat refractory angina patients. However, this procedure needs to be evaluated in larger patient populations.
655    _2
$a kazuistiky $7 D002363
700    1_
$a Jiravsky, Otakar $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia $u Faculty of Medicine, Masaryk University, Kamenice 735/5, Brno 625 00, Czechia
700    1_
$a Spacek, Radim $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia
700    1_
$a Neuwirth, Radek $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia $u Faculty of Medicine, Masaryk University, Kamenice 735/5, Brno 625 00, Czechia
700    1_
$a Knybel, Lukas $u Department of Oncology, University Hospital Ostrava, 17. listopadu 5, Ostrava 708 00, Czechia
700    1_
$a Sknouril, Libor $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia
700    1_
$a Cvek, Jakub $u Department of Oncology, University Hospital Ostrava, 17. listopadu 5, Ostrava 708 00, Czechia
700    1_
$a Miklik, Roman $u Department of Cardiology, Nemocnice Agel Trinec-Podlesi, Konska 453, Trinec 739 61, Czechia
773    0_
$w MED00200140 $t European heart journal. Case reports $x 2514-2119 $g Roč. 5, č. 8 (2021), s. ytab184
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34514297 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013134051 $b ABA008
999    __
$a ind $b bmc $g 1708174 $s 1144537
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 5 $c 8 $d ytab184 $e 20210831 $i 2514-2119 $m European heart journal. Case reports $n Eur Heart J Case Rep $x MED00200140
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...